Clin2
NCT05424978Possibly a fitRecruiting

Standardized green-channel treatment for acute stroke care

Acute Ischemic StrokeThrombolysisEndovascular Treatment

Part of Brain & nervous system, Heart & circulation clinical trials.

This study tests a structured, fast way of treating people who have a new ischemic stroke (a stroke caused by a blocked blood vessel). It may help because it focuses on getting the right stroke treatments quickly and consistently.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
3,600 people
Ages
18 years to 100 years
Study type
Observational

Who can take part

  • Be at least 18 years old
  • Have a confirmed new acute ischemic stroke
  • Start of symptoms must be within 24 hours before enrollment
  • Agree to take part and sign informed consent
  • Be willing to receive standard stroke treatments like IV thrombolysis or procedures if needed

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07840794Not yet recruiting
Combined brain-protecting treatments for recent ischemic stroke

This study tests a combination of gentle brain-protecting treatments (temperature, oxygen, positioning, and nerve stimulation) given alongside standard clot-busting therapy for recent strokes. The goal is to see if the combination can help improve recovery and reduce disability after a stroke.

NCT07137832Recruiting· Phase 3
Testing clot-busting drug during stroke treatment for medium vessel blockages

This trial tests whether giving a clot-dissolving medication directly into the brain's blood vessels during a standard procedure (mechanical thrombectomy) can improve outcomes for people with a stroke caused by a blockage in a medium-sized artery. It may be an option for patients who arrive at the hospital within 24 hours of symptom onset and have enough salvageable brain tissue.

Guangzhou, Guangdong
NCT07115940Recruiting
Clot removal after 24 hours for stroke patients

This trial tests if removing a large blood clot from the brain up to 3 days after a stroke improves recovery compared to standard medical care alone. It is for patients who have a severe stroke and are otherwise healthy enough for the procedure.

Chicago, Illinois
NCT06749834Recruiting· Phase 3
Clot-busting drug after stroke in people on newer blood thinners

This trial tests whether a clot-busting medication given through a vein (intravenous thrombolysis) can safely treat acute ischemic stroke within 24 hours in people who have taken a newer oral blood thinner (NOAC) within the last 4 to 48 hours.

Hangzhou, Zhejiang
NCT07356284Recruiting· Phase 3
Stroke treatment study for blocked arteries with narrowing

This study tests a rescue treatment for people having a major stroke caused by a blocked artery in the brain that also has severe narrowing. If doctors can't fully open the artery with standard clot removal, this study looks at whether additional treatments can help.

Toledo, Ohio
NCT07052045Recruiting
One-stop emergency care for fast stroke treatment

This trial tests a streamlined approach to quickly start endovascular therapy for people having a severe ischemic stroke caused by a blocked large or medium brain artery. It aims to reduce delays and improve recovery by coordinating the care team as soon as you arrive at the hospital.

Nuremberg

Hear when a new Acute Ischemic Stroke trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.